| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 573,924 | 520,659 | 415,393 | 442,584 | | Cost of Revenue | (269,415) | 328,224 | 1,223,193 | 23,229 | | | Gross Profit | 843,339 | 192,435 | (807,800) | 419,355 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 688,435 | 72,105 | (846,056) | 361,938 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 59,086 | 61,134 | 70,391 | 71,418 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 95,818 | 59,196 | (32,135) | (14,001) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 95,818 | 59,196 | (32,135) | (14,001) | | Interest Expense | 23,938 | 23,221 | 23,696 | 26,000 | | Income Before Tax | 71,880 | 35,975 | (55,831) | (40,001) | | Income Tax Expense | 27,189 | 13,543 | (20,543) | (15,049) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 44,691 | 22,432 | (35,288) | (24,952) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 44,691 | 22,432 | (35,288) | (24,952) | | Preferred Stock And Other Adjustments | (3,164) | (2,918) | (3,240) | (3,241) | | | Net Income Applicable To Common Shares | $41,527 | $19,514 | ($38,528) | ($28,193) |
|
0.50% Nasdaq 0.00%
Income Statement
